Skip to content

Efficacy of Ultrasound-Guided Local Anesthetic Injection Into or Around the Sciatic Nerve for Lower Limb Anesthesia

Intraneural Injection of Ropivacaine for Subgluteal Sciatic Nerve Block Leads to Faster Onset and Higher Success Rates: a Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01999647
Enrollment
64
Registered
2013-12-03
Start date
2011-12-31
Completion date
2012-12-31
Last updated
2013-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot Diseases, Injuries, Foot, Injuries, Knee, Injuries, Leg, Orthopedic Disorders

Keywords

Lower Extremity, Sciatic Nerve, Anesthetics, Local, Ropivacaine, Ultrasonography

Brief summary

This study was designed to assess whether the injection of local anesthetic into the nerve (intraneural), as opposed to around it (perineural), requires a shorter time to develop surgical anesthesia of the lower leg. The investigators will compare the two types of injection using the same drug, so as to determine if there is an actual difference onset time. They will also examine the overall success rate of either kind of sciatic nerve blocks as the sole anesthetic for non-emergent orthopedic surgery. The safety of these procedures will be examined by in-hospital and phone-call follow-up contacts.

Detailed description

This will be a randomized, controlled, patient- and observer-blinded trial assessing block characteristics after intra- or perineural injection of ropivacaine for subgluteal sciatic nerve blocks performed for elective surgery of the lower limb.

Interventions

The injection will start as the needle penetrates the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as intraneural if nerve cross section expansion and a reduction in echogenicity are observed. Short-axis real-time ultrasound imaging will be used, with an in-plane needle approach.

The injection will start as the needle indents the outermost discernible layer of the nerve (epineurium) under ultrasound guidance. The injection will be adjudicated as intraneural if the drug infiltrates the space between the epimysium of the surrounding muscles and the outer epineurium of the sciatic nerve. Short-axis real-time ultrasound imaging will be used, with an in-plane needle approach.

PROCEDUREFemoral Nerve Block

Patients will receive an ultrasound-guided femoral nerve block using a short- or long-acting local anesthetic, as deemed indicated.

Patients will receive a patient-controlled intravenous or perineural catheter-based analgesia, depending on their preference and the anesthesiologist's indication.

DRUGRopivacaine

Thirty milliliters of 0.75% (wt/vol) ropivacaine will be used for the sciatic nerve block.

Sponsors

University of Parma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergoing non-emergent orthopedic procedure of knee, leg, foot with thigh tourniquet * ASA Physical Status Class I-III * Consenting to surgery under peripheral nerve block anesthesia (sciatic + femoral/saphenous block)

Exclusion criteria

* Unable to understand or communicate for the purpose of the study * Exhibiting any neurological disturbance of the ipsilateral lower extremity * Inability to satisfactorily image the sciatic nerve in the opinion of the attending anesthesiologist

Design outcomes

Primary

MeasureTime frameDescription
Onset Time of Sciatic Nerve Block≤30 minutes after block performanceTime to onset of sciatic nerve anesthesia, defined as both following criteria: * Sensory: does not feel pain or discomfort when pricked with a 25G needle. * Motor: able to slightly curl toes; unable to flex the ankle.

Secondary

MeasureTime frameDescription
Success Rate of Sciatic Nerve Blocks≤30 min after block performanceThe percentage of patients who attain the criteria for block success within 30 minutes of the injection. Investigators will also report the percentage of patients who successfully complete surgery without significant additional analgesia (see below); this will be defined as clinical success rate.
Incidence and Prevalence of Neurologic Disturbances30 days after anesthesia performancePatients will be interviewed at \ 4 h (block resolution visit), 7 days and (if necessary) at 30 days to assess for residual neurologic disturbances in the sciatic nerve territory. The incidence/prevalence of these phenomena will be noted.
Differences in Time to Resolution of Sciatic Nerve Block<12 hThe time at which sensory and motor function of the sciatic nerve have recovered at least to the following criteria: * Sensory: patients feel discomfort when pricked with a thin needle (25G) * Motor: patients may move both toes and ankle, albeit with reduced strength This outcome measure will be examined by an investigator every 30-60 min and reported by patients as time to return of sensation and movement. The investigator-reported value will be preferred if both are available.

Other

MeasureTime frameDescription
Extra- vs. Intraneural Minimum Electrical Stimulation ThresholdsDuring performance of nerve block (<30 min)The minimum electrical nerve stimulation threshold will be recorded as a function of needle tip position.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026